Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pharma Technologies Ltd. Dexcel currently holds 98,849,443 shares of Intec Pharma Ltd. (NTEC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Technologies Ltd. Dexcel has been a net buyer of NTEC stock. They have purchased $58.5M and sold $282.5K worth of shares.
Pharma Technologies Ltd. Dexcel's most recent insider trade was on Apr 25, 2022, when they purchased 8,600 shares at $3.91 per share.
Pharma Technologies Ltd. Dexcel serves as Executive at Intec Pharma Ltd. (NTEC). They have executed 25 insider transactions totaling $58.8M over their tenure at the company.
Pharma Technologies Ltd. Dexcel holds the position of Executive at Intec Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Pharma Technologies Ltd. Dexcel has shown a buying trading pattern, with $58.5M in total purchases and $282.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Pharma Technologies Ltd. Dexcel was on Oct 1, 2018, when they purchased $37.5M worth of UROV shares. This transaction involved 2,678,571 shares at $14.00 per share.
Pharma Technologies Ltd. Dexcel currently owns 98,849,443 shares of Intec Pharma Ltd. (NTEC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pharma Technologies Ltd. Dexcel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pharma Technologies Ltd. Dexcel has 25 Form 4 filings on record as an insider at Intec Pharma Ltd..
Set alerts for Pharma Technologies Ltd. Dexcel and 40,000+ other insiders.